Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Shankar

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
British Journal of Haematology|February 22, 2017
Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groupsAnanth G Shankar, Gaelle Roques, Amy A Kirkwood, et al.
Blood Advances|June 3, 2026
​EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphomaAnanth G Shankar, Judith Landman-Parker, Maurizio Mascarin, et al.
Molecular Psychiatry|August 21, 2013
Discovery and validation of blood biomarkers for suicidalityH Le-Niculescu, D F Levey, M Ayalew, et al.
Molecular Psychiatry|August 19, 2015
Understanding and predicting suicidality using a combined genomic and clinical risk assessment approachA B Niculescu, D F Levey, P L Phalen, et al.
Blood Advances|April 14, 2026
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analysesJamie E Flerlage, Dennis A Eichenauer, Michael Fuchs, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
British Journal of Haematology|February 22, 2017
Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groupsAnanth G Shankar, Gaelle Roques, Amy A Kirkwood, et al.
Blood Advances|June 3, 2026
​EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphomaAnanth G Shankar, Judith Landman-Parker, Maurizio Mascarin, et al.
Molecular Psychiatry|August 21, 2013
Discovery and validation of blood biomarkers for suicidalityH Le-Niculescu, D F Levey, M Ayalew, et al.
Molecular Psychiatry|August 19, 2015
Understanding and predicting suicidality using a combined genomic and clinical risk assessment approachA B Niculescu, D F Levey, P L Phalen, et al.
Blood Advances|April 14, 2026
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analysesJamie E Flerlage, Dennis A Eichenauer, Michael Fuchs, et al.
Pageof 14